Clinical Trial

3 articles

Microscopic view of lung cancer cells being targeted by Pfizer's lorlatinib, illustrating a breakthrough in targeted cancer therapy and improved patient survival rates.

Pfizer lung cancer drug: 60% progression-free after five years

After five years, 60% of patients with a specific type of lung cancer treated with Pfizer's lorlatinib were still alive without their disease progressing, a dramatic finding compared to just 8% on the

Marcus Cole·June 23, 2026

Microscopic view of cancer cells being targeted by a glowing therapeutic agent, representing Revolution Medicines' experimental drug.

Cosmos & Space

Revolution Medicines' Experimental Pancreatic Cancer Drug Shows Promise

Revolution Medicines' experimental drug daraxonrasib doubled the median overall survival for patients with metastatic pancreatic cancer to 13.2 months in its pivotal Phase 3 trial.

David Grossman·May 31, 2026

A detailed, glowing stem cell heart patch being applied to a human heart during a medical procedure, symbolizing hope and innovation in cardiac treatment.

Cosmos & Space

Stem cell heart patch increases heart wall thickness in patients

In a small clinical trial, patients with advanced heart failure who received a stem cell-based heart patch saw their heart wall thickness increase by 4.

Marcus Cole·May 28, 2026